Product Information

KETODAN 2% FOAM is a generic product labeled by Medimetriks Pharmaceuticals Inc., priced at $3.2761 per GM under NDC 43538053010. Its NADAC has been published 125 times since Nov 28, 2013.

FDA first approved this application on Aug 25, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the ketoconazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

KETODAN 2% FOAM

ketoconazole
$3.2761per GM
High Outlier

Strength

20 mg/g

NDC

43538053010

Classification

Generic

Dosage Form

AEROSOL, FOAM

Route

TOPICAL

Effective Date

8/19/2026

Active Ingredients

KETOCONAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA091550

FDA Approved

8/25/2011

TE Code

AB

On Market Since

6/15/2012

Pharmacological Classes

Azole Antifungal
Azoles
Cytochrome P450 3A4 Inhibitors
Cytochrome P450 3A5 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for KETODAN 2% FOAM has been published 125 times since Nov 28, 2013, and over the history we have for it it has risen 13.6%. The table below summarizes its recorded NADAC range and movement.

Current price$3.2761 per GM
All-time high$3.8345 (Nov 13, 2024)
All-time low$2.3325 (Jan 21, 2026)
52-week high$3.2761
52-week low$2.3325
Median price$3.0293
Average price$3.0551
Largest weekly change+26.8% (Jul 17, 2024)
Weeks tracked125
Tracking sinceNov 28, 2013

Price History

1W

+4.8%

1M

+4.8%

3M

+7.7%

6M

+29.3%

1Y

+32.5%

3Y

+13.6%

5Y

+13.6%

All

+13.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ketoconazole market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of KETODAN 2% FOAM?

The current National Average Drug Acquisition Cost (NADAC) for KETODAN 2% FOAM, manufactured by Medimetriks Pharmaceuticals Inc., is $3.2761 per GM (NDC 43538053010), effective Aug 19, 2026.

How has the price of KETODAN 2% FOAM changed over time?

Over the history we have for it, the NADAC for KETODAN 2% FOAM has risen 13.6%. It has been tracked across 125 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for KETODAN 2% FOAM?

Since Nov 28, 2013, the NADAC for KETODAN 2% FOAM has ranged from a low of $2.3325 (Jan 21, 2026) to a high of $3.8345 (Nov 13, 2024), with a median of $3.0293 per GM.

Are there cheaper alternatives to KETODAN 2% FOAM?

No other NADAC-published product currently shares the active ingredient and strength of KETODAN 2% FOAM in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures KETODAN 2% FOAM?

KETODAN 2% FOAM (NDC 43538053010) is labeled by Medimetriks Pharmaceuticals Inc., and CMS classifies it as a generic product.